- Impact of Non-technical Skills Training on Performance and Effectiveness of a Medical Emergency TeamCondition: Medical Staff Non-technical Skills
Intervention: Other: Non-technical skills training
Sponsors: Lyell McEwin Hospital; Lyell McEwin Hospital
Not yet recruiting - verified March 2012 - Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: AV nodal ablation; Drug: Medical Ventricular Rate Control
Sponsors: University of Adelaide; University of Adelaide
Not yet recruiting - verified January 2012 - Conditions: Smoking; Addiction
Intervention: Drug: Nicabate 21mg Transdermal Nicotine Replacement Therapy (NRT)Patch
Sponsors: The Queen Elizabeth Hospital; The Queen Elizabeth Hospital; Basil Hetzel Institute for Translational Research; University of Adelaide; University of South Australia; Clinical Practice Unit; Therapeutics Research Centre
Recruiting - verified September 2011 - Condition: Heart Transplantation
Intervention:
Sponsors: University Hospital Birmingham; Nigel E. Drury
Not yet recruiting - verified August 2011 - Condition: Ulcerative Colitis
Interventions: Drug: Rectal tactolimus; Drug: Placebo
Sponsors: The University of Western Australia; The University of Western Australia; Mater Health Services' Adult Hospital, Brisbane, Qld; Concord Hospital; The Canberra Hospital; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified August 2011 - Condition: Pain
Intervention:
Sponsors: IX Biopharma Pte. Ltd.; IX Biopharma Pte. Ltd.
Recruiting - verified June 2011 - Conditions: Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate Cancer
Intervention: Other: Non-Interventional Study
Sponsors: Trans-Tasman Radiation Oncology Group (TROG); Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified June 2011 - Condition: Opioid Dependence
Intervention: Drug: Fentanyl
Sponsors: University of Adelaide; University of Adelaide
Not yet recruiting - verified May 2011 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2011 - Condition: Medication Overuse Headache
Interventions: Drug: Ibudilast; Drug: Placebo
Sponsors: University of Adelaide; University of Adelaide; University of South Australia
Recruiting - verified October 2011 - Conditions: Cystic Fibrosis; Bronchiectasis
Interventions: Drug: Azithromycin; Drug: Placebo control
Sponsors: Queensland Children's Medical Research Institute; Queensland Children's Medical Research Institute; Telethon Institute for Child Heath Research
Enrolling by invitation - verified May 2012 - Condition: Spinal Cord Injury
Interventions: Device: Therastride Treadmill System; Device: FES-assisted cycling; Other: Trunk and upper and lower limb exercises; Other: Upper body strength and fitness program
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Life Time Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified August 2010 - Conditions: Metabolic Syndrome; Diabetes
Intervention: Dietary Supplement: high fat overfeeding
Sponsors: University of Adelaide; University of Adelaide
Recruiting - verified October 2010 - Condition: Atrial Fibrillation
Intervention: Procedure: DE-MRI
Sponsors: University of Utah; University of Utah
Active, not recruiting - verified February 2012 - Condition: Ankle Fractures
Interventions: Procedure: Open reduction internal fixation of the ankle; Procedure: Non Operative
Sponsors: The University of New South Wales; The University of New South Wales; Whitlam Orthopaedic Research Centre; CROSSBAT Investigators
Recruiting - verified January 2012 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Condition: Traumatic Brain Injury
Interventions: Drug: Epoetin Alfa; Drug: Placebo, Sodium Chloride
Sponsors: Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Research Centre; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative; Australian and New Zealand Intensive Care Society Clinical Trials Group; Monash University
Recruiting - verified April 2012 - Condition: Severe Sepsis
Interventions: Other: Standard Care; Other: Early Goal Directed Therapy (EGDT)
Sponsors: Monash University; Belinda Howe; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian College for Emergency Medicine
Recruiting - verified April 2012 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified May 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Condition: Breast Cancer
Interventions: Procedure: axillary lymph node dissection; Procedure: No axillary lymph node dissection
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Active, not recruiting - verified February 2012 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: CAF regimen; Drug: CMF regimen; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: methotrexate; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); International Breast Cancer Study Group
Recruiting - verified September 2008 - Condition: Lung Cancer
Interventions: Biological: BCG vaccine; Biological: monoclonal antibody BEC2
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Completed - verified March 2012
 |
Join Clinical Trials by University in South Australia, Australia |
